Amgen - M&A Summary and Business Overview

Life ScienceCompany

Amgen M&A Summary

Amgen has acquired 21 companies, including 6 in the last 5 years. A total of 3 acquisitions came from private equity firms.

Amgen’s largest acquisition to date was in 2022, when it acquired Horizon Therapeutics Public Limited Company for $27.8B. Amgen has acquired in 5 different US states, and 6 countries. The Company’s most targeted sectors include life science (96%) and medical products (5%).

Amgen Business Overview

Where is Amgen headquartered?

Amgen is headquartered in Thousand Oaks, California.

What is Amgen’s revenue?

Amgen disclosed revenue of 28,190M USD for 2023 and 26,323M USD for 2022.

How many employees does Amgen have?

Amgen has 26,700 employees.

What sector is Amgen in?

Amgen is a life science company.

When was Amgen founded?

Amgen was founded in 1980.

M&A Summary

  • M&A Total Activity21
    • M&A Buy Activity21
  • Total Sectors Invested 2
  • Total Countries Invested 6
  • M&A Buy/Sell Connections 4
  • M&A Advisors 11

Amgen

Amgen, Inc.

One Amgen Center Drive,
Thousand Oaks, California 91320
United States,
(805) 447-1000
www.amgen.com

Amgen is a drug development company focused on discovering, developing, manufacturing and delivering human therapeutics. Amgen uses tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and people's lives. Amgen was founded in 1980 and is based in Thousand Oaks, California.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (1.0/yr) # 16 - 3 2 - - 21
vol $48.3B $3.5B $31.5B $83.3B
Sell (0.0/yr) # - - - - - - 0
  21

Most Recent M&A

Company Date Value Type
Horizon Therapeutics Public Limited Company 2022-12-12 27.8B USD Add-on Acquisition
Dublin, Ireland · www.horizontherapeutics.com
ChemoCentryx, Inc. 2022-08-04 3.7B USD Add-on Acquisition
San Carlos, California · www.chemocentryx.com
Teneobio, Inc. 2021-07-27 900M USD Add-on Acquisition
Newark, California · www.teneobio.com
Rodeo Therapeutics Corp. 2021-03-30 721M USD Add-on Acquisition
Seattle, Washington · www.rodeotherapeutics.com
Five Prime Therapeutics, Inc. 2021-03-04 1.9B USD Add-on Acquisition
South San Francisco, California · www.fiveprime.com
Otezla 2019-08-26 13.4B USD Divestiture
, United States
Dezima Pharma BV 2015-09-16 - Add-on Acquisition
Naarden, Netherlands · www.dezimapharma.com
Onyx Pharmaceuticals, Inc. 2013-08-25 10.4B USD Add-on Acquisition
South San Francisco, California · www.onyx-pharm.com
deCODE genetics, Inc. 2012-12-10 415M USD Add-on Acquisition
Reykjavik, Iceland · www.decode.com
Mustafa Nevzat Pharmaceuticals 2012-04-25 700M USD Add-on Acquisition
Istanbul, Turkey · www.mn.com.tr
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 20 (95%) 83.1B (100%) - -
Medical Products 1 (5%) 215M (< 1%) - -
Total 21 $83.3B - -

By Geo

State/Country Buy Value Sell Value
United States 16 54.2B - -
  California 9 21.4B - -
  Massachusetts 3 1.5B - -
  Washington 2 16.7B - -
  Maryland 1 1.2B - -
Brazil 1 215M - -
Iceland 1 415M - -
Ireland 1 27.8B - -
Netherlands 1 - - -
Turkey 1 700M - -
Domestic 16 (76%) 54.2B (65%) - -
Cross-border 5 (24%) 29.1B (35%) - -
Total 21 $83.3B - -

Top M&A Advisors

Financial Deals
Goldman Sachs
2
Lazard Ltd.
1
Moelis & Co.
1
Legal Deals
Sullivan & Cromwell
5
Latham & Watkins
1
Wachtell, Lipton, Rosen & Katz
1

Deal Values

buy # Total
> $1B 10 $78.9B
$100M to $1B 10 $4.4B
TOTAL $83.3B
Largest Horizon Therapeutics Public Limited Company
$27.8B (2022-12-12)

M&A Connections

Deals
Acquired from
Investor(s)
14%
3 (14%)
Strategic(s)
5%
1 (5%)

 Subscribe to unlock this and 204,477
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 196K M&A Transactions
  • 200K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 78K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.